the World Health Organization (WHO) has announced. The first patient has been enrolled in DR Congo, WHO chief Tedros Adhanom Ghebreyesus said on Thursday. More than 1,400 cases and 438 deaths have been confirmed in the country, according to the WHO. There are currently no approved vaccines or treatments for the Bundibugyo virus species of the disease, which is highly infectious. The current trial is sponsored by the WHO, and is being co-ordinated by scientists at the Institut National de Recherche Biomédicale in DR Congo, the Institute of Tropical Medicine in Belgium, and the University of Oxford in the UK. Patients will be tested on two antiviral drugs. Speaking to reporters from the WHO headquarters in Geneva on Thursday, Tedros said: "Even without approved therapeutics, people are recovering from this disease, but of course, we could save many more lives with safe and effective therapeutics in our toolkit." DR Congo's Health Minister Dr Samuel Roger Kamba said the launch "represents a significant step forward, offering renewed hope to patients, their families, and affected communities". (BBC)